| 
			
			 Laws that only require women to be told they have dense breasts, 
			without any further information, don't seem to make a difference in 
			extra screenings or cancers detected, the study team reports in 
			American Journal of Public Health. 
 Roughly half of U.S. women in their 40s and 50s have dense breast 
			tissue, which increases their risk of breast cancer and makes it 
			harder to detect tumors with mammography. Several states require 
			healthcare providers to send notification letters to women whose 
			mammograms show dense breast tissue. Some states also require that 
			these higher-risk women be advised to get screened with ultrasound 
			or MRI, which can better detect tumors in dense breast tissue.
 
 A new proposal from the U.S. Food and Drug Administration, announced 
			March 27, would require all mammography facilities in the U.S. to 
			include breast density information in letters to patients. The FDA 
			says it is proposing "specific language that would explain how 
			breast density can influence the accuracy of mammography," but the 
			agency's announcement does not say the letters must advise about 
			further testing options.
 
			
			 
			
 For the current study, researchers examined data on screening and 
			cancer diagnoses for more than 1.4 million women ages 40 to 59 in 
			nine states with dense breast notification laws and 25 states 
			without these laws.
 
 "We found that dense breast notification laws were associated with 
			small increases in cancer detection," said lead study author Susan 
			Busch of the Yale School of Public Health in New Haven, Connecticut.
 
 "This effect was only found in states with laws that included 
			language about the benefits of supplemental testing," Busch said by 
			email. "We did not have enough follow-up data to take the next step 
			and determine whether dense breast notification laws were associated 
			with reduced breast cancer mortality."
 
 The goal of mammograms is to detect tumors before they can be felt 
			in a physical breast exam, catching cancer sooner when it's easier 
			to treat. Ideally, this should mean fewer women are diagnosed when 
			tumors are more advanced.
 
			
            [to top of second column] | 
            
			 
			It's not clear from the current study to what extent dense breast 
			notification laws might lead to so-called over-diagnosis, which can 
			cause women to undergo needless testing or treatments for relatively 
			harmless tumors; it's also not clear how many lives might be saved 
			by catching aggressive cancers sooner when they're easier to treat. 
			Very few women in the study got recommended ultrasounds after 
			screening mammograms found dense breast tissue, even though 
			insurance covers these tests, the researchers note.
 Women with dense breasts should continue to get mammograms and 
			should also speak to their doctor to determine what screening plan 
			is best for them, advised Dr. Catherine Tuite, chief of breast 
			radiology at Fox Chase Cancer Center in Philadelphia.
 
 "Mammography is still the gold standard for the detection of breast 
			cancer, even for women with dense breasts, and multiple studies have 
			proven that detection of cancers by mammography reduces the risk of 
			death due to breast cancer for women starting at age 40," Tuite, who 
			wasn't involved in the study, said by email.
 
 "Women diagnosed with breast cancer who participate in screening 
			mammography are less likely to die from breast cancer than those who 
			do not," Tuite added. "Supplemental screening tests such as 
			screening whole breast ultrasound, MRI or MBI are not a substitute 
			for mammography because there are still some cancers and 
			precancerous changes that will show on a mammogram better than on 
			other tests."
 
			
			 
			SOURCE: https://bit.ly/2V6ww4I American Journal of Public Health, 
			online March 21, 2019. 
			[© 2019 Thomson Reuters. All rights 
				reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. |